Trials / Completed
CompletedNCT01060930
Diesel Exhaust Inhalation, Systemic Nitric Oxide Inhibition and Cardiac Output
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- University of Edinburgh · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Exposure to combustion-derived fine particulate air pollution is associated with cardiovascular mortality and morbidity. In previous studies, exposure to diesel exhaust (a major constituent of urban particulate air pollution) has been shown to impair two important functions of the vascular endothelium: vascular vasomotor function and endogenous fibrinolysis. Our subsequent studies suggest this impairment of vascular function is mediated by a reduction in nitric oxide bioavailability. In this study we aim to investigate the cardiovascular responses to systemic nitric oxide synthase inhibition following exposure to dilute diesel exhaust.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Intravenous infusion of L-NMMA and Nor-epinephrine | Intravenous infusion of 3mg/kg L-NMMA (L-NG-monomethyl arginine; NO synthase inhibitor) and nor-epinephrine at 50 ng/kg/min. Each infusion to run over 15 mins and separated by 45 min to allow return to baseline. Drugs infused in a randomised order. During the study, blood pressure will be measured invasively using an intra-arterial radial artery cannula, central arterial stiffness measured using peripheral arterial tonometry and cardiac output using thoracic bioimpedance. |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2010-02-02
- Last updated
- 2011-12-16
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT01060930. Inclusion in this directory is not an endorsement.